Buy, sell, hold recommendations from top Indian brokerages
144 articles
Following a Nifty rebound, market analysts are recommending Varun Beverages and JSW Energy for potential short-term gains, citing bullish technical indicators.
Global financial giants Jefferies and Goldman Sachs have issued optimistic outlooks for the Indian steel industry, pinpointing robust growth prospects for key players like JSW Steel [JSWSTEEL].
Paytm shares saw an initial dip after RBI's Paytm Payments Bank licence cancellation but quickly recovered as Jefferies, Goldman Sachs, and Bernstein maintained positive ratings, citing limited financial impact on the core business.
Shriram Finance shares saw a notable dip of nearly 4% after declaring strong Q4 FY24 results, yet prominent brokerages like Nomura and Motilal Oswal maintain a 'Buy' rating, citing robust fundamentals and future growth potential.
IndusInd Bank [INDUSINDBK] witnessed a significant share price rally following its impressive Q4 FY24 earnings, with profit soaring and asset quality showing considerable improvement. This strong performance has led several leading brokerages, including Jefferies, to revise their target prices upwards.
Reliance Industries [RELIANCE] shares saw a modest dip after announcing a 13% year-on-year drop in Q4 net profit, despite robust revenue growth. While near-term challenges persist, major brokerages like Morgan Stanley and Goldman Sachs maintain a broadly positive outlook, highlighting potential for recovery and sustained growth across key segments.
Axis Bank [AXISBANK] recently reported a subdued Q4FY24 performance, with net profit showing a marginal decline, prompting a dip in its share price and prompting brokerages to reassess their views.
Leading brokerage firms have identified PNB Housing Finance [PNBHOUSING] and Fortis Healthcare [FORTIS] as potential long-term investment opportunities, projecting 10-20% returns by 2026.
Religare Broking's Ajit Mishra has expressed a positive outlook on Bajaj Auto [BAJAJ_AUTO], anticipating an upside for the stock as the broader auto sector gains traction in the market.
Adani Green Energy [ADANIGREEN] is set to invest a massive ₹42,000 crore in FY27, targeting a 5 GW increase in its clean energy capacity, as brokerage firm UBS issues a 'BUY' rating on the stock.
Amidst recent market volatility, LKP Securities' Senior Technical Analyst, Rupak De, has identified two stocks – Aster DM Healthcare [ASTERDM] and AU Small Finance Bank [AUBANK] – as 'Buy' recommendations for potential near-term gains of up to 8%.
Global brokerage UBS has identified significant growth potential in select Nifty Mid-Cap 100 stocks, projecting upsides of 30% to 60% over the next year for ten specific companies.
Amidst the escalating West Asia crisis, Sanjeev Prasad of Kotak Institutional Equities warns of significant macroeconomic challenges for India, presenting 'bad' and 'ugly' scenarios. Despite this, he suggests Nifty 50 earnings could remain resilient due to insulated sectors.
Dr. Reddy's Laboratories [DRREDDY] shares saw a notable decline today following a downgrade from Goldman Sachs and cautious remarks from Citigroup, citing limited growth visibility and pipeline concerns.
Global financial giant JPMorgan has downgraded Indian equities to 'Neutral' from 'Overweight', citing concerns over elevated valuations and geopolitical risks. The firm warns of a potential 15% downside for the Nifty, projecting it could dip to 20,500 in a bear-case scenario.
Global brokerage HSBC has revised its outlook on Indian equities, downgrading the country to 'underweight' due to persistent inflationary pressures from elevated oil prices and robust domestic demand.
BEML Ltd [BEML], a prominent capital goods company, is reportedly showing signs of a bullish comeback after dropping more than 20% from its recent highs. Technical analysts are recommending a 'Buy' with a target of ₹2,200.
Amidst Nifty's current weakness, market analysts are recommending Dr. Reddy's Laboratories [DRREDDY] and Solar Industries [SOLARINDS] as potential buys, citing bullish signals and strong momentum for gains up to 14%.
Technical analysts have identified potential intraday trading opportunities in a leading pharmaceutical firm and a mid-cap online insurance stock, forecasting gains of up to 6% for today.
Tata Communications [TATACOMM] shares climbed over 5% following its Q4 FY24 results, driven by robust data revenue growth. Despite a significant drop in net profit, analysts are maintaining a positive outlook.